# Aether Holdings, Inc.: financial statements, quarterly

ATHR · Nasdaq · CIK 2026353 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/athr.md) · [Financials](/companies/athr/financials.md) · [Filings](/companies/athr/filings.md) · [Insiders](/companies/athr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/athr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | [365](/filings/0001641172-25-011279.md) | [357](/filings/0001641172-25-024844.md) | [353 d](/filings/0001493152-25-028195.md) | [355](/filings/0001493152-26-007146.md) | [342](/filings/0001493152-26-023858.md) | [342](/filings/0001493152-26-037828.md) | [342 d](/filings/0001493152-25-028195.md) | [339](/filings/0001493152-26-007146.md) | [336](/filings/0001493152-26-023858.md) | [329](/filings/0001493152-26-037828.md) |
| Cost of revenue | $k | not reported | [110](/filings/0001641172-25-011279.md) | [110](/filings/0001641172-25-024844.md) | [112 d](/filings/0001493152-25-028195.md) | [108](/filings/0001493152-26-007146.md) | [110](/filings/0001493152-26-023858.md) | [103](/filings/0001493152-26-037828.md) | [83.0 d](/filings/0001493152-25-028195.md) | [66.4](/filings/0001493152-26-007146.md) | [64.8](/filings/0001493152-26-023858.md) | [64.5](/filings/0001493152-26-037828.md) |
| Gross profit | $k | not reported | [256](/filings/0001641172-25-011279.md) | [246](/filings/0001641172-25-024844.md) | [240 d](/filings/0001493152-25-028195.md) | [247](/filings/0001493152-26-007146.md) | [232](/filings/0001493152-26-023858.md) | [239](/filings/0001493152-26-037828.md) | [259 d](/filings/0001493152-25-028195.md) | [272](/filings/0001493152-26-007146.md) | [271](/filings/0001493152-26-023858.md) | [264](/filings/0001493152-26-037828.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [57.9](/filings/0001493152-26-007146.md) | [73.2](/filings/0001493152-26-023858.md) | [101](/filings/0001493152-26-037828.md) |
| Income tax | $k | not reported | not reported | [0.0](/filings/0001641172-25-024844.md) | [0.0 d](/filings/0001493152-25-028195.md) | not reported | [5.3](/filings/0001641172-25-011279.md) | [0.0](/filings/0001641172-25-024844.md) | [0.0 d](/filings/0001493152-25-028195.md) | not reported | not reported | not reported |
| Net income | $k | [(93.9)](/filings/0001641172-25-024844.md) | [(182)](/filings/0001641172-25-024844.md) | [(299)](/filings/0001641172-25-024844.md) | [(364) d](/filings/0001493152-25-028195.md) | [(322)](/filings/0001493152-26-037828.md) | [(390)](/filings/0001493152-26-037828.md) | [(1,006)](/filings/0001493152-26-037828.md) | [(1,423) d](/filings/0001493152-25-028195.md) | [(1,297)](/filings/0001493152-26-037828.md) | [(1,029)](/filings/0001493152-26-037828.md) | [(1,343)](/filings/0001493152-26-037828.md) |
| Diluted EPS | $ per share | not reported | [(0.02)](/filings/0001641172-25-011279.md) | [(0.03)](/filings/0001641172-25-024844.md) | not reported | [(0.03)](/filings/0001493152-26-007146.md) | [(0.04)](/filings/0001493152-26-023858.md) | [(0.08)](/filings/0001493152-26-037828.md) | not reported | [(0.11)](/filings/0001493152-26-007146.md) | [(0.08)](/filings/0001493152-26-023858.md) | [(0.11)](/filings/0001493152-26-037828.md) |
| Basic EPS | $ per share | not reported | [(0.02)](/filings/0001641172-25-011279.md) | [(0.03)](/filings/0001641172-25-024844.md) | not reported | [(0.03)](/filings/0001493152-26-007146.md) | [(0.04)](/filings/0001493152-26-023858.md) | [(0.08)](/filings/0001493152-26-037828.md) | not reported | [(0.11)](/filings/0001493152-26-007146.md) | [(0.08)](/filings/0001493152-26-023858.md) | [(0.11)](/filings/0001493152-26-037828.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | not reported | not reported | not reported | [192](/filings/0001493152-25-028195.md) | not reported | [179](/filings/0001641172-25-011279.md) | [187](/filings/0001641172-25-024844.md) | [160](/filings/0001493152-26-037828.md) | [263](/filings/0001493152-26-007146.md) | [216](/filings/0001493152-26-023858.md) | [254](/filings/0001493152-26-037828.md) |
| Current assets | $k | not reported | not reported | not reported | not reported | [716](/filings/0001493152-25-028195.md) | not reported | [365](/filings/0001641172-25-011279.md) | [6,512](/filings/0001641172-25-024844.md) | [4,783](/filings/0001493152-26-037828.md) | [2,150](/filings/0001493152-26-007146.md) | [1,083](/filings/0001493152-26-023858.md) | [2,668](/filings/0001493152-26-037828.md) |
| Total assets | $k | not reported | not reported | not reported | not reported | [719](/filings/0001493152-25-028195.md) | not reported | [368](/filings/0001641172-25-011279.md) | [6,523](/filings/0001641172-25-024844.md) | [5,036](/filings/0001493152-26-037828.md) | [4,007](/filings/0001493152-26-007146.md) | [2,982](/filings/0001493152-26-023858.md) | [4,636](/filings/0001493152-26-037828.md) |
| Current liabilities | $k | not reported | not reported | not reported | not reported | [603](/filings/0001493152-25-028195.md) | not reported | [964](/filings/0001641172-25-011279.md) | [583](/filings/0001641172-25-024844.md) | [519](/filings/0001493152-26-037828.md) | [637](/filings/0001493152-26-007146.md) | [641](/filings/0001493152-26-023858.md) | [792](/filings/0001493152-26-037828.md) |
| Total liabilities | $k | not reported | not reported | not reported | not reported | [603](/filings/0001493152-25-028195.md) | not reported | [964](/filings/0001641172-25-011279.md) | [583](/filings/0001641172-25-024844.md) | [519](/filings/0001493152-26-037828.md) | [637](/filings/0001493152-26-007146.md) | [641](/filings/0001493152-26-023858.md) | [3,628](/filings/0001493152-26-037828.md) |
| Shareholders' equity | $k | [(673)](/filings/0001493152-25-028195.md) | [283](/filings/0001641172-25-024844.md) | [362](/filings/0001641172-25-024844.md) | [383](/filings/0001641172-25-024844.md) | [116](/filings/0001493152-26-037828.md) | [(206)](/filings/0001493152-26-037828.md) | [(596)](/filings/0001493152-26-037828.md) | [5,940](/filings/0001493152-26-037828.md) | [4,517](/filings/0001493152-26-037828.md) | [3,370](/filings/0001493152-26-037828.md) | [2,341](/filings/0001493152-26-037828.md) | [1,009](/filings/0001493152-26-037828.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(303)](/filings/0001641172-25-024844.md) | [(385) d](/filings/0001493152-25-028195.md) | [(258)](/filings/0001493152-26-007146.md) | [(104) d](/filings/0001493152-26-023858.md) | [(1,998)](/filings/0001641172-25-024844.md) | [(1,572) d](/filings/0001493152-25-028195.md) | [(1,008)](/filings/0001493152-26-007146.md) | [(919) d](/filings/0001493152-26-023858.md) | [(1,189) d](/filings/0001493152-26-037828.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | [1.2 d](/filings/0001493152-25-028195.md) | [1,169](/filings/0001493152-26-007146.md) | [0.0 d](/filings/0001493152-26-023858.md) | [6.5 d](/filings/0001493152-26-037828.md) |
| Share repurchases | $k | not reported | [(35.8) d](/filings/0001493152-25-028195.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.5](/filings/0001641172-25-011279.md) | [10.0](/filings/0001641172-25-024844.md) | [10.0](/filings/0001493152-26-007146.md) | [10.0](/filings/0001493152-26-023858.md) | [11.9](/filings/0001493152-26-037828.md) | [12.1](/filings/0001493152-26-007146.md) | [12.1](/filings/0001493152-26-023858.md) | [12.1](/filings/0001493152-26-037828.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,238,059 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037828.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.